Oral Presentation Asia Pacific Stroke Conference 2024

Perivascular Space Progression In Patients With Cerebral Amyloid Angiopathy (107369)

Qi Li 1 , Maria Clara Zanon Zotin 2 , Susanne van Veluw 2 , Valentina Perosa 2 , Edip Gurol 2 , Joshua Goldstein 3 , Anand Viswanathan 2 , Steven Greenberg 2
  1. The Second Affiliated Hospital of Anhui Medical University, Shushan, ANHUI PROVINCE, China
  2. Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
  3. Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

BACKGROUND: Dilated perivascular spaces (dPVS) seen on MRI are associated with small vessel disease in the aging population. We sought to investigate the incidence and dynamic evolution of MRI-detectable PVS progression in patients with cerebral amyloid angiopathy (CAA). 

METHODS: Patients with symptomatic CAA who underwent baseline and follow-up MRI scans >2 years apart were included. The distribution and severity of both basal ganglia and centrum semiovale PVS were rated. Multivariable logistic regression was used to determine the risk factors for MRI-detectable PVS progression. 

RESULTS: We included 90 patients with CAA, of which 53 (58.9%) had intracerebral hemorrhage (ICH) at baseline. During a median follow-up of 4.8 years (IQR: 3.6-6.6 years), MRI-detectable PVS progression was observed in 24 patients (26.7%) at follow-up MRI. After adjusting for age, hypertension and time interval between baseline and follow-up MRI, cerebral microbleed (CMB) progression (OR: 4.12, 95% CI: 1.31 to 12.95; p=0.015) and presence of ICH (OR: 8.61, 95% CI: 2.09 to 35.52; p=0.003) were independent predictors of PVS progression. In multivariable regression analysis, presence of ICH (OR: 9.22, 95% CI: 1.81 to 47.08; p=0.008) and hypertension (OR: 5.20, 95% CI 1.14 to 23.77; p=0.033) were associated with MRI-detectable BG-PVS progression. However, only CMB progression (OR: 10.15, 95% CI: 1.82 to 56.45; p=0.008) was associated with CSO-PVS progression.

CONCLUSIONS: MRI-detectable PVS progression occurs in a subset of CAA patients reimaged after a median of 4.8 years and is associated with CMB progression. PVS progression might be a useful neuroimaging marker for visualizing CAA-related vascular changes.